American Cancer Society awards $28M in grants
Click Here to Manage Email Alerts
American Cancer Society has awarded $28 million in new extramural discovery science research and career development grants to fund investigators across several U.S. institutions beginning in July 2024.
“We are very proud to announce these new grant awardees and their critically important research projects,” Christina Annunziata, MD, PhD, senior vice president of extramural discovery science at [American Cancer Society (ACS)],” said in a press release. “These scientists have dedicated their lives to increasing our understanding of better ways to treat and survive cancer, and we look forward to partnering with them in our collective mission to help save lives.”
The awards “require fundamental, preclinical, clinical, population and implementation/dissemination research as well as multidisciplinary team science to tackle the complexities of cancers and cancer care,” according to the release.
Ann H. Partridge, MD, MPH, founder and director of the Program for Young Adults with Breast Cancer and director of the adult survivorship program at Dana-Farber Cancer Institute, is one of two recipients of the ACS Professor Award, which recognizes investigators who have made seminal contributions in cancer research and recognizes exceptional track records in leadership, service and mentoring in cancer research, according to the release.
“With this support from the ACS, we will focus on the growing number of young adult patients and survivors,” Partridge told Healio. “Improved attention to the unique concerns of this patient population should improve their disease and psychosocial outcomes.”
Partridge and colleagues plan to inform cancer care and interventions to improve treatment outcomes and support quality of life across the broader adolescent and young adult population, and disseminate interventions to diverse community oncology practices, as well as create a workforce of investigators who will continue work to benefit adolescent and young adults with cancer, according to the release.
“We are excited these grants will fund a range of innovative research across different cancer types,” William L. Dahut, MD, chief scientific officer at ACS, said in the release. “These studies include intervention approaches and research methodologies that highlight basic molecular research, immunotherapy, preclinical and clinical trials, prospective cohort studies, and even AI and computational machine learning.”
Click Here to Manage Email Alerts